Previous Page  9 / 17 Next Page
Information
Show Menu
Previous Page 9 / 17 Next Page
Page Background

Page 35

I n t e r n a t i o n a l C o n f e r e n c e o n

Physicians, Surgeons and

Case Reports

November 19-20 , 2018

Par i s , France

Medical Case Reports

ISSN: 2471-8041

PSCR 2018

T

he strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a

positive result on government deficit. The investment law approved recently has good statements and rules on the above

strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced

radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched

towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost

sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given

in this study. Also, it highlights the current drug supply system in the public sector, which is currently responsibility of the Central

Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative

studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or

low quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the

public health is protected against by marketing high quality medicines rather than commercial interests, and the drug companies

are held accountable for their conduct.

abdeenomer2@yahoo.co.uk

Medicine distribution in Sudan

Abdeen Mustafa Omer

Federal Ministry of Health Sudan, Sudan

Med Case Rep. 2018, Volume:4

DOI: 10.21767/2471-8041-C2-006